8 July 2026 in Turkish Journal of Cerebrovascular Diseases
Background: Mechanical thrombectomy is recommended for patients with middle cerebral artery (MCA) segment 1 (M1) occlusion within 6 hours of symptom onset by American Stroke Association. This study aimed to demonstrate the safety of endovascular treatments in MCA M1 infarcts and compare the safety and effectiveness of direct thrombectomy and intravenous tissue plasminogen activator (iv-tPA) bridging therapy before mechanical thrombectomy. Methods: A retrospective, observational study was conducted on patients with large MCA infarction on brain imaging. Patients who received endovascular treatment were included in the endovascular therapy (EVT) group, while who received only iv-tPA were included in the iv-tPA group. Patients who underwent direct mechanical thrombectomy or bridging therapy were identified. Clinical outcomes at 3 months and symptomatic intracerebral hemorrhage (SIH) rates were compared between the groups. Results: The EVT group showed good clinical outcomes (modified Rankin score [mRS] ≤ 2) at 3 months was significantly higher than the iv-tPA group, while; SIH rates were similar. There was no statistically significant difference in terms of good clinical outcomes between direct mechanical thrombectomy and bridging therapy groups. But, SIH rates were significantly higher in the direct mechanical thrombectomy group. Conclusion: Our study showed that for large MCA infarct, EVT provides better clinical outcomes than iv-tPA alone, and that direct mechanical thrombectomy may be an effective choice for patients who are unsuitable for iv-tPA. Additionally, our findings also contribute to the literature indicating that bridging therapy is a safe option.
15 February 2026 in Turkish Journal Of Neurology
Objectives: This study aims to evaluate the efficacy, safety, and complications of intravenous thrombolytic therapy (IVTT), identify the prognostic factors in treated patients, and assess outcomes in patients aged over 80 years. Patients and methods: Between June 2014 and March 2020, 155 patients with acute ischemic stroke were enrolled in this retrospective observational study and assigned to the IVTT group (44 males, 37 females; median age: 69 years; IQR, 58–79 years) and the non-IVTT group (30 males, 44 females; median age: 74 years; IQR, 65–82 years). The modified Rankin scale score at the third month for all patients and hemorrhagic transformation rates in the IVTT group were recorded. Outcomes were compared between patients aged over and under 80 years within the IVTT group. Results: Good outcomes at the third month were significantly higher in the IVTT group than in the non-IVTT group (37% vs. 17.6%, p = 0.007), with symptomatic intracerebral hemorrhage occurring in 6.2% of patients within the first 36 h after IVTT; baseline National Institutes of Health Stroke Scale (NIHSS) score and age were independent predictors of favorable outcomes. Conclusion: In our study, IVTT reduced the disability at the third month and can be safely performed in carefully selected patients. In older patients or those with high NIHSS scores, alternative therapies may also be considered.